A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer
Clinical trial NCT03314324 · COMPLETED
Trial details
- NCT number
- NCT03314324
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2022-01-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.